Malaria Campaigners Hopeful on Drugs Pricing Deal

Published in September 9th, 2008

Comments Off

Anti-malaria campaigners are confident that a deal can be reached with pharmaceuticals groups to cut the cost of new drugs needed to fight a disease estimated to kill more than 1 million people a year.
Reuters Health Information

Pfizer to withdraw global marketing applications for Dalbavancin to conduct a new trial

Published in September 9th, 2008

Posted by Pharmaceutical News Feed in Drugs and Food Information, Pharmaceutical Industry News

Comments Off

Pfizer Inc today announced it will globally withdraw all dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. new drug application (NDA) and the European marketing authorization application (MAA).

New nanotechnology paints for hospitals could kill superbugs

Published in September 9th, 2008

Posted by Pharmaceutical News Feed in Drugs and Food Information, Pharmaceutical Industry News

Comments Off

New nanotechnology paints for walls, ceilings, and surfaces could be used to kill hospital superbugs when fluorescent lights are switched on, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology’s Autumn meeting being held this week at Trinity College, Dublin.

Hurricane Gustav Tested Disaster Preparedness Lessons Learned During Katrina

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Better communications, smaller patient census, and plenty of backup power are keys to disaster preparedness, New Orleans hospital administrators say.
Medscape Medical News

Iron Therapy in CKD Patients — Harm or Benefit?

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Rajiv Agarwal, MD, Professor of Medicine at Indiana University, discusses the risks and benefits of IV iron therapy, including how parenteral iron therapy may be used given this risk-benefit profile.

Medscape Nephrology

Solvay Pharmaceuticals Acquires Innogenetics

Published in September 9th, 2008

Posted by Drugs.com - Pharma News in Drugs and Food Information, Pharmaceutical Industry News

Comments Off

BRUSSELS, Belgium, Sept. 8, 2008–Solvay Pharmaceuticals S.A., a subsidiary of the Solvay Group, the chemical and pharmaceutical group, today announced that it succeeded to acquire Innogenetics N.V., a Belgian-based biotechnological company,…

Less Sleep Linked to Greater Risk of Falling in Elderly Women

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

A study shows that women who are aged 70 years and older who sleep 5 hours or less per night may be more likely to experience falls than those who sleep more than 7 to 8 hours per night.
Medscape Medical News

MRI May Help Predict Response to Anti-Tumor Necrosis Factor Therapy for Ankylosing Spondylitis

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

A study shows that spinal inflammation on MRI may predict therapeutic response to anti-tumor necrosis factor therapy for ankylosing spondylitis.
Medscape Medical News

Intensive BP and Glucose-Lowering Additive in Diabetic Patients: ADVANCE

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

The ADVANCE trial suggests that aggressively targeting glucose and blood pressure levels reduces nephropathy and renal events, and also reduces the risk for cardiovascular death by almost 25%.
Medscape Medical News

Postmenopausal Hormonal Therapy May Increase Risk for GERD

Published in September 9th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

The risk for gastroesophageal reflux disease is increased for postmenopausal use of estrogens, selective estrogen receptor modulators, or over-the-counter hormone preparations.
Medscape Medical News

« Older Entries